Zilver PTX Post-Market Study in Japan

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 909 participants.

Also called NCT02254837

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 909 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02254837
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02254837. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2018-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Zilver PTX Post-Market Study in Japan
Condition
Peripheral Arterial Disease (PAD)
Intervention (Device)
Zilver PTX Drug-Eluting Stent
Lead sponsor
Cook Group Incorporated (class: industry)

Record details

Record id
cardio:ct-nct02254837
Content hash
4129ee86977d99e5d0e26f791c495cb3561b47ac4a44c7dbb32d43e13ef44a75